Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.47 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.40 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.40 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.40 |
| ▸ | SENP3 | Q9H4L4 | 1/20 | 0.40 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.40 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL15653006 | 1.00 | MYC (0.47) | MYCRAPGEF4ALDH1A1KDM4EHPGD | |
| 1,3-Propanediol SCHEMBL1502277 | 0.92 | MYC (0.44) | MYCRAPGEF4ALDH1A1KDM4EHPGD | |
| Alcohol SCHEMBL27960969 | 0.92 | RAPGEF4 (0.49) | MYCRAPGEF4ALDH1A1KDM4EHPGD | |
| SCHEMBL29392580 | 0.91 | MYC (0.53) | MYCRAPGEF4ALDH1A1KDM4EGAA | |
| SCHEMBL1748 | 0.91 | MYC (0.53) | MYCRAPGEF4ALDH1A1KDM4EGAA | |
| Monoethanolamine SCHEMBL8423206 | 0.90 | MYC (0.43) | MYCRAPGEF4ALDH1A1KDM4EHPGD | |
| Alcohol SCHEMBL28156310 | 0.90 | RAPGEF4 (0.47) | MYCRAPGEF4ALDH1A1KDM4EHPGD | |
| SCHEMBL6916771 | 0.89 | MYC (0.52) | MYCRAPGEF4ALDH1A1KDM4EGAA | |
| SCHEMBL948871 | 0.89 | MYC (0.52) | MYCRAPGEF4ALDH1A1KDM4EGAA | |
| Ammonia Solution, Strong SCHEMBL6360239 | 0.89 | MYC (0.52) | MYCRAPGEF4ALDH1A1KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116209723-A | Desalination of water using complexing agents attached to magnetic nanoparticles | NWPT-纳米净水科技有限公司 | 2023-06-02 | — | — | CN | disclosed |
| CN-114514303-A | Liquid crystal aligning agent for vertical alignment, liquid crystal alignment film, and liquid crystal display element | 日产化学株式会社 | 2022-05-17 | — | — | CN | disclosed |
| CN-110914270-B | Preparation method of pirlindole enantiomer and salt thereof | 社会医疗技术员技术股份公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-110871039-B | Salt tolerant anion exchange media | 帕尔公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-112969959-A | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | 日产化学株式会社 | 2021-06-15 | — | — | CN | disclosed |
| CN-112912792-A | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same | 日产化学株式会社 | 2021-06-04 | — | — | CN | disclosed |
| CN-106986748-B | Oligofluorenediols, oligofluorenediaryl esters, and methods for producing these | 三菱化学株式会社 | 2020-10-09 | — | — | CN | disclosed |
| CN-110914270-A | Preparation method of pirlindole enantiomer and salt thereof | 社会医疗技术员技术股份公司 | 2020-03-24 | — | — | CN | disclosed |
| CN-110871039-A | Salt tolerant anion exchange media | 帕尔公司 | 2020-03-10 | — | — | CN | disclosed |
| US-20110097269-A1 | PHENYLOXYANILINE DERIVATIVES | LEHMANN LUTZ | 2011-04-28 | — | — | US | disclosed |
| US-7803960-B2 | Phenyloxyaniline derivatives | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-09-28 | — | — | US | disclosed |
| CN-101535241-A | Phenyloxyaniline derivatives | BAYER SCHERING PHARMA AG (DE) | 2009-09-16 | — | — | CN | disclosed |
| EP-2064176-A1 | PHENYLOXYANILINE DERIVATIVES | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-06-03 | — | — | EP | disclosed |
| US-20080177108-A1 | Phenyloxyaniline derivatives | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-07-24 | — | — | US | disclosed |
| WO-2008028533-A1 | PHENYLOXYANILINE DERIVATIVES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-03-13 | — | — | WO | disclosed |
| EP-1894915-A1 | Phenyloxyaniline derivatives | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-03-05 | — | — | EP | disclosed |
| US-6312882-B1 | PRECIPITATING SILVER HALIDE IN A PROTECTIVE COLLOIDAL SILICA, CONTROLLING NUCLEATION, SUBJECTING TO PHYSICAL RIPENING, DESALTING, CHEMICAL RIPENING | AGFA-GEVAERT (BE) | 2001-11-06 | — | — | US | disclosed |
| EP-0602254-B1 | POLYMERIZABLE MONOMER, POLYMER THEREOF, AND PROCESS FOR PRODUCING THE SAME | OTSUKA KAGAKU KK (JP) | 1997-01-02 | — | — | EP | disclosed |
| US-5476913-A | Bactericides | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1995-12-19 | — | — | US | disclosed |
| EP-0602254-A1 | POLYMERIZABLE MONOMER, POLYMER THEREOF, AND PROCESS FOR PRODUCING THE SAME | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1994-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110097269-A1 | PHENYLOXYANILINE DERIVATIVES | PNMT, PAH, NAT1 | MYC 821/4885RAPGEF4 1044/4885ALDH1A1 430/4885 |
| US-20080177108-A1 | Phenyloxyaniline derivatives | PNMT, PAH, NAT1 | MYC 821/4885RAPGEF4 1044/4885ALDH1A1 430/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.